REG - Concepta PLC - Director/PDMR Shareholding

MyhealthcheckedAnnouncement

27/04/2020 08:20

RNS Number : 9415K
  
Concepta PLC
  
27 April 2020
  
 

Concepta PLC
("Concepta" or the "Company") 
 
Directors/PDMR Shareholding
 
Concepta plc (AIM: CPT), the innovative UK personalised healthcare company and developer of the proprietary self-test platform ("myLotus®"), the UK's most accurate home-use fertility tracking and pregnancy testing system, announces that following Admission of the Placing Shares and Subscription Shares to trading this morning, the following new ordinary shares of 0.1p ("Ordinary Shares") have been issued to the Directors at 0.8p per Ordinary Share.
 



Name


Number of Ordinary Shares subscribed


Number of Ordinary Shares held post Admission


% of Ordinary Share Capital held post Admission




Penny McCormick


1,250,000


1,250,000


0.26%




Maddy Kennedy


1,250,000


1,250,000


0.26%




Lyn Rees


1,562,500


1,562,500


0.32%




Adam Reynolds


6,250,000


8,084,722


1.65%



 
All terms used above are as defined in the RNS of 8 April 2020.
 



Concepta plc


www.conceptaplc.com




Penny McCormick, Chief Executive Officer


via Walbrook PR




Maddy Kennedy, Chief Financial Officer


















SPARK Advisory Partners Limited (NOMAD)


Tel: +44 (0)20 3368 3550




Neil Baldwin 


















Novum Securities (Broker)


Tel: +44 (0)20 7399 9400




Colin Rowbury


















Walbrook PR Ltd (Media & Investor Relations)


Tel: +44 (0)20 7933 8780 or concepta@walbrookpr.com




Paul McManus


Mob: +44(0)7980 541 893 







 
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 


Penny McCormick




2 
 


Reason for the notification 
 




a) 
 


Position/status 
 
 


Chief Executive Officer




b) 
 


Initial notification /Amendment 
 
 


Initial Notification




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 
 


CONCEPTA plc




b) 
 


LEI 
 
 


213800RBHY6LZDG13168
 




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
 




a) 
 


Description of the financial instrument, type of instrument 


Ordinary Shares
 














Identification code


ISIN: GB00BYZ2R301




 








b) 
 


Nature of the transaction 
 
 


Subscription for cash




c) 
 


Price(s) and volume(s) 


 


 


 


 








 


Price(s)


Volume(s)


 








 


£0.008


1,250,000


 








 


 


 


 




d) 
 


Aggregated information 


















- Aggregated volume


As above














- Price


















e) 
 


Date of the transaction 
 
 


27 April 2020




f) 
 


Place of the transaction 
 


London Stock Exchange, AIM



 




 
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 


Maddy Kennedy




2 
 


Reason for the notification 
 




a) 
 


Position/status 
 
 


Chief Financial Officer




b) 
 


Initial notification/Amendment 
 
 


Initial Notification




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 
 


CONCEPTA plc




b) 
 


LEI 
 
 


213800RBHY6LZDG13168
 




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
 




a) 
 


Description of the financial instrument, type of instrument 


Ordinary Shares
 














Identification code


ISIN: GB00BYZ2R301




 








b) 
 


Nature of the transaction 
 
 


Subscription for cash




c) 
 


Price(s) and volume(s) 


 


 


 


 








 


Price(s)


Volume(s)


 








 


£0.008


1,250,000


 
 








 


6,250,000 of these shares were acquired by the spouse of Mrs Kennedy.


 


 




d) 
 


Aggregated information 


















- Aggregated volume


As above














- Price


















e) 
 


Date of the transaction 
 
 


27 April 2020




f) 
 


Place of the transaction 
 


London Stock Exchange, AIM



 
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 


Lyn Rees




2 
 


Reason for the notification 
 




a) 
 


Position/status 
 
 


Non-Executive Director




b) 
 


Initial notification /Amendment 
 
 


Initial Notification




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 
 


CONCEPTA plc




b) 
 


LEI 
 
 


213800RBHY6LZDG13168
 




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
 




a) 
 


Description of the financial instrument, type of instrument 


Ordinary Shares
 














Identification code


ISIN: GB00BYZ2R301




 








b) 
 


Nature of the transaction 
 
 


Subscription for cash




c) 
 


Price(s) and volume(s) 


 


 


 


 








 


Price(s)


Volume(s)


 








 


£0.008


1,562,500


 








 


 


 


 




d) 
 


Aggregated information 


















- Aggregated volume


As above














- Price


















e) 
 


Date of the transaction 
 
 


27 April 2020




f) 
 


Place of the transaction 
 


London Stock Exchange, AIM



 




 
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 


Adam Reynolds




2 
 


Reason for the notification 
 




a) 
 


Position/status 
 
 


Non-Executive Chairman




b) 
 


Initial notification /Amendment 
 
 


Initial Notification




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 
 


CONCEPTA plc




b) 
 


LEI 
 
 


213800RBHY6LZDG13168
 




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
 




a) 
 


Description of the financial instrument, type of instrument 


Ordinary Shares
 














Identification code


ISIN: GB00BYZ2R301




 








b) 
 


Nature of the transaction 
 
 


Subscription for cash




c) 
 


Price(s) and volume(s) 


 


 


 


 








 


Price(s)


Volume(s)


 








 


£0.008


6,250,000


 








 


 


 


 




d) 
 


Aggregated information 


















- Aggregated volume


As above














- Price


















e) 
 


Date of the transaction 
 
 


27 April 2020




f) 
 


Place of the transaction 
 


London Stock Exchange, AIM



 




 
About Concepta PLC (www.conceptaplc.com) 
 
Concepta PLC is an AIM-quoted pioneering UK healthcare company that has developed a proprietary product, myLotus®, targeted at the personalized mobile health market with a primary focus on hormone testing and increasing a woman's chances of naturally getting pregnant and to provide insight to unexplained infertility.
 
myLotus® is currently the only consumer product which allows both quantitative and qualitative home (self-test) test measurement of a woman's personal luteinizing hormone (LH) during ovulation and human chorionic gonadotropin (hCG) hormone level during pregnancy, facilitating higher conception rates and early diagnosis of fertility issues. The proposition of myLotus® is to empower women to better understand their hormone levels and menstrual cycle and help women conceive naturally by identifying their window of fertility and optimal time for conception.
 
The Company has received CE-mark certification for myLotus® and has launched its first product in the UK. The Company is preparing plans to roll-out across the core EU countries in 2020. 
 
myLotus® is expected to be beneficial to users who have been unable to conceive after 6 months of trying. This highly motivated target group of women won't typically be offered medical intervention until after 12 months of unsuccessfully trying to conceive, with IVF not usually offered until after two years of trying to conceive. Research indicates couples start to take positive action ahead of this time typically with little medical support to help them do so.
 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHPPUWGCUPUUMM